United Leukodystrophy Foundation
We’re pleased to share that the United Leukodystrophy Foundation has shared our press release, marking yet another avenue of informing […]
We’re pleased to share that the United Leukodystrophy Foundation has shared our press release, marking yet another avenue of informing […]
We are passionate about serving our clients by providing the highest quality vector and leading the industry in technological advancements. […]
We are thrilled to have a spotlight in National Venture Capital Association‘s (NVCA) Building Better blog series alongside Molly (McCartin) Bonakdarpour of Drive […]
Read More… from “Building Better” Blog: Forge Biologics Spotlight
With new beginnings comes new hope. As we enter 2021, screening will begin for the our Phase 1/2 RESKUE trial […]
Read More… from RESKUE Trial for Patients with Krabbe Disease
As we begin 2021, we’d like to introduce you to our new Blaze Vector™ AAV production line. Utilizing our proprietary […]
In the spirit of football season, we’re introducing our very own roster of seasoned #genetherapy players. Our leadership team has […]
Read More… from Our Gene Therapy Players: The Starting Lineup
From all of us at Forge Biologics, we wish you a safe and happy holiday season!#hopeisalive #happyholidays #raredisease #genetherapy #aav #lifesciences #innovation #biotechnology #GMP […]
Forge Biologics is a #genetherapy manufacturing and development company helping clients achieve their cGMP program goals. Forge enables AAV vector production at […]
Your next career is here. https://www.forgebiologics.com/careers […]